[Shock-wave therapy of angina pectoris from positions of general pathology].
Iargin
S V
SV
D000787:Angina Pectoris / Q000503:physiopathology / Q000628:therapy*; D000818:Animals; D003331:Coronary Vessels / Q000473:pathology / Q000503:physiopathology; D004285:Dogs; D019220:High-Energy Shock Waves / Q000009:adverse effects*; D006801:Humans; D032383:Myocytes, Cardiac / Q000473:pathology; D018919:Neovascularization, Physiologic / Q000528:radiation effects; D009569:Nitric Oxide / Q000502:physiology; D035703:Therapies, Investigational / Q000009:adverse effects; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology; D014664:Vasodilation / Q000528:radiation effects
D042461:Vascular Endothelial Growth Factor A; D009569:Nitric Oxide